Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
X-Seb T Plus is a topical medicated shampoo formulated with a combination of coal tar and salicylic acid, primarily indicated for the management of inflammatory and scaling scalp conditions such as dandruff, seborrheic dermatitis, and psoriasis. Coal tar acts as a keratoplastic agent that slows the rapid proliferation of skin cells and reduces inflammation and itching, likely through the activation of the aryl hydrocarbon receptor (AhR) and the inhibition of DNA synthesis. Salicylic acid serves as a keratolytic agent, facilitating the removal of excess scales by dissolving the intercellular matrix in the stratum corneum. This dual-action approach addresses both the underlying cellular hyperproliferation and the visible scaling associated with chronic scalp disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on X-Seb T Plus.